TY  - JOUR

T1  - Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

JO  - Bone Marrow Transplantation

UR  - https://doi.org/10.1038/s41409-021-01540-2

PY  - 2021/12/01

AU  - Czerw T

AU  - Iacobelli S

AU  - Malpassuti V

AU  - Koster L

AU  - Kröger N

AU  - Robin M

AU  - Maertens J

AU  - Chevallier P

AU  - Watz E

AU  - Poiré X

AU  - Snowden JA et al

ED  - 

DO  - DOI: 10.1038/s41409-021-01540-2

PB  - Springer Science and Business Media LLC

VL  - 57

IS  - 2

SP  - 261

EP  - 270

Y2  - 2025/11/15

ER  -